WebFind the latest DermTech, Inc. (DMTK) stock quote, history, news and other vital information to help you with your stock trading and investing. WebApr 14, 2024 · SAN DIEGO, April 14, 2024 -- ( BUSINESS WIRE )--Zura Bio Limited (Nasdaq: "ZURA") ("Zura Bio"), a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, today announced the appointment of Michael D. Howell, Ph.D., to the role of Chief Scientific Officer and …
DermTech, Inc. (DMTK) Stock Price Today, Quote & News
WebJan 23, 2024 · LA JOLLA, Calif., January 23, 2024--DermTech, Inc. (NASDAQ: DMTK) ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced ... WebDermTech to Present at March Investor Conferences. Events. Oppenheimer 33rd Annual Healthcare Conference, Virtual. Mar 14, 2024 at 10:00 AM EDT. Click here for webcast. TD Cowen 43rd Annual Health … jim shepard the world to come
Zura Bio Announces Appointment of Chief Scientific Officer
WebSun joined DermTech Operations in August 2024 and served in the role of Vice President, Finance. From June 2008 to November 2024, Mr. Sun served in various management and executive roles for Dexcom, Inc. (Nasdaq:DXCM) including most recently as Vice President, Corporate Controller and Treasury from November 2024 to November 2024, as Interim ... WebJun 22, 2024 · DermTech sees the market in melanoma testing to be as big as 4.5 million tests they hope to disrupt. For UV damage and skin cancer risk testing, DermTech sees … WebDec 26, 2024 · The DermTech Melanoma Test is a precision genomic test that lets us look past the skin’s cells — deep within skin’s genes — to help find and assess disease earlier. “If detected early, the five-year survival rate for melanoma can be as high as 99 percent . instant cash wayne rd